{"result": "(\"entity\"<|>AMERICAN THYROID ASSOCIATION<|>ORGANIZATION<|>The American Thyroid Association provides guidelines for the diagnosis and management of thyroid disease during pregnancy and postpartum.)\n##\n(\"entity\"<|>DANISH NATIONWIDE STUDY<|>EVENT<|>A study conducted in Denmark examining birth defects after early pregnancy use of antithyroid drugs.)\n##\n(\"entity\"<|>GRAVES DISEASE<|>EVENT<|>Graves disease is an autoimmune disorder that causes hyperthyroidism, particularly in pregnant women.)\n##\n(\"entity\"<|>SECISBP2<|>PERSON<|>SECISBP2 is a selenoprotein involved in the metabolism of thyroid hormones, with mutations leading to abnormal thyroid hormone metabolism.)\n##\n(\"entity\"<|>HYPERTENSION<|>EVENT<|>A condition that can occur during pregnancy, often requiring careful management to avoid complications.)\n##\n(\"entity\"<|>HYPERTIROIDISM<|>EVENT<|>A condition characterized by excessive thyroid hormone production, which can affect pregnancy outcomes.)\n##\n(\"entity\"<|>THYROID HORMONE METABOLISM<|>EVENT<|>The process by which thyroid hormones are produced and regulated in the body, crucial for normal physiological functions.)\n##\n(\"relationship\"<|>AMERICAN THYROID ASSOCIATION<|>GRAVES DISEASE<|>The American Thyroid Association provides guidelines specifically addressing the management of Graves disease during pregnancy<|>8)\n##\n(\"relationship\"<|>DANISH NATIONWIDE STUDY<|>HYPERTENSION<|>The Danish nationwide study investigates the effects of antithyroid drugs, which can relate to hypertension in pregnant women<|>6)\n##\n(\"relationship\"<|>SECISBP2<|>THYROID HORMONE METABOLISM<|>Mutations in SECISBP2 affect thyroid hormone metabolism, leading to various thyroid-related disorders<|>7)\n##\n(\"relationship\"<|>HYPERTIROIDISM<|>GRAVES DISEASE<|>Graves disease is a common cause of hyperthyroidism, particularly in pregnant women<|>9)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 3 provocan que\n     placentaria y causar en el feto un cuadro de hipertiroidismo transitorio, lo que ocurre en el                                              los niveles de esta última a nivel nuclear sean bajos, con el consiguiente escaso efecto\n     1-2% de las mujeres gestantes con enfermedad de Graves (opción D). Por este motivo se                                                      biológico a pesar de niveles elevados periféricos de T4. Este cuadro se ha descrito en\n     recomienda estrecha vigilancia fetal en las mujeres gestantes con hipertiroidismo no con-                                                  unos     pocos     casos     que    presentan       mutación       a   nivel   de   una    selenoproteína         (SECISBP2)\n     trolado durante la segunda mitad del embarazo y en mujeres con niveles elevados de TSI en                                                  que está integrada en la estructura de las desyodasas que catalizan la conversión de T4 en\n     cualquier momento del mismo.                                                                                                               T3 y rT3,    así como de T3 en T2 (opciones B y C ciertas).\n     Por consiguiente, la respuesta correcta a esta pregunta es la B.                                                                           Por consiguiente, tanto la opción B, como la C son verdaderas, por lo que la respuesta co-\n     Referencias:                                                                                                                               rrecta a esta pregunta es la D.\n     • Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C, et al. 2017 Guidelines of the American Thyroid Association for the\n       Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017;27:315-89.                                Referencias:\n     • Andersen SL, Olsen J, Wu CS, Laurberg P. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study. J      • Dumitrescu AM, Liao XH, Abdullah MS, Lado-Abeal J, Majed FA, Moeller LC, et al. Mutations in SECISBP2 result in abnormal thyroid\n       Clin Endocrinol Metab. 2001;98:4373-81.                                                                                                    hormone metabolism. Nat Genet. 2005;37:1247-52.\n     • Bahn RS, Burch HS, Cooper DS, Garber JR, Greenlee CM, Klein IL, et al. The role of propylthiouracil in the management of Graves’         • Dumitrescu AM, Liao XH, Best TB, Brockmann K, Refetoff S. A novel syndrome combining thyroid and neurological abnormalities is\n       disease in adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration.         associated with mutations in a monocarboxylate transporter gene. Am J Hum Genet. 2004;74:168-75.\n       Thyroid. 2009;19:673-4.                                                                                                                  • Refetoff S, Bassett JH, Beck-Peccoz P, Bernal J, Brent G, Chatterjee K, et al. Classification and proposed nomenclature for inherited\n     • Cooper DS, Laurberg P. Hyperthyroidism in pregnancy. Lancet Diabetes Endocrinol. 2013;1:238-49.                                            defects of thyroid hormone action, cell transport, and metabolism. Thyroid. 2014;24:407-9.\n     • Gargallo M. Hyperthyroidism and pregnancy. Endocrinol Nutr. 2013;60:535-43.                                                              • Singh BK, Yen PM. A clinician’s guide to understanding resistance to thyroid hormone due to receptor mutations in the TRα and TRβ\n     • Mandel SJ, Cooper DS. The use of antithyroid drugs in pregnancy and lactation. J Clin Endocrinol Metab. 2001;86:2354-9.                    isoforms. Clin Diabetes Endocrinol. 2017;3:8.\n     • Russo MW, Galanko JA, Shrestha R, Fried MW, Watkins P. 2004 Liver transplantation for acute liver failure from drug induced liver\n       injury in the United States. Liver Transpl. 2004;10:1018-23.\n     • Yoshihara A, Noh J, Yamaguchi T, Ohye H, Sato S, Sekiya K, et al. Treatment of Graves’ disease with antithyroid drugs in the first\n       trimester of pregnancy and the prevalence of congenital malformation. J Clin Endocrinol Metab. 2012;97:2396-403.\n     • Zimmerman D. Fetal and neonatal hyperthyroidism. Thyroid. 1999;9:727-33.\n\n\n\n160                                                                                                                                                                                                                                                                                  161\n---\n                                                                                                                                                                                                                              TIROIDES                        3\n\n\n\n     23  En relación con el diagnóstico diferencial entre los tumores hipofisarios                                                    con macroadenomas hipofisarios, lo que ayuda en su diferenciación de los cuadros de re-\n         productores de TSH y la resistencia a las hormonas tiroideas (RHT), señale                                                   sistencia a hormonas tiroideas (opción D verdadera).\n         la afirmación falsa:                                                                                                         Referencias:\n                                                                                                                                      • Beck-Peccoz P, Lania A, Beckers A, Chatterjee K, Wemeau J.-L. 2013 European Thyroid Association Guidelines for the Diagnosis and\n         A. La respuesta\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}